CODHy 2025’s Program
2025 PROGRAM TO BE UPDATE
2024 Program for Reference
MAY 31 FRIDAY 2024
| CODHy Congress Scientific Program | |||
| HALL A | HALL B | HALL C | |
| 11:00-12:00 Frontier Progress in Blood Lipid Management Forum 血脂管理前沿进展论坛 | 10:00-11:30 Innovation in Cardiovascular and Metabolic Diseases心血管-代谢性疾病创新专题 | 09:00-12:00MMC Session MMC 专题 | |
| 12:00-14:00 | Lunch Symposium A | Lunch Symposium B | Lunch Symposium C |
| 14:00-17:00 | Session 1| Innovation in Obesity and Diabetes 糖尿病与肥胖中的创新 Chairs: Luc Van Gaal, Belgium; Juliana Chan，HK SAR ; Chen Li, China; Li Xiaoying, China Precision Medicine in Young-onset Diabetes年轻发病糖尿病的精准医疗 Juliana Chan，HK SAR 20min Progress in Clinical Research and Treatment of Obesity in China中国肥胖临床研究和治疗进展 Mu Yiming，China 20min New Concept on Healthy Therapy-Human Insulin Enteric-coated Capsules clinical glimmer of hope健康治疗新概念-人胰岛素肠溶胶囊临床展望 Bian Xiaolan，China 20min The Collision of Digital Nutrition and Dietary Therapy数字营养与饮食治疗的碰撞 Shi Yongmei，China 20min New and Future Developments in Anti-obesity Agents: Where do we go to？抗肥胖药物的新发展和未来发展:我们将走向何方? Luc Van Gaal, Belgium 20min Early Screening and Warning for Diabetic Microvascular Complications Based on the MMC Platform 基于MMC平台的糖尿病微血管并发症早期筛查和预警 Zhang Yifei，China 20min Accurate and Individual-independent Non-invasive Glucose Monitoring based on Depth-Selected Raman Spectroscopy 通过深度可选拉曼光谱实现的精准且通用的无创血糖监控技术 Chen Chang ,China 20min Discussion 40 Min | Session 2| BPROAD Session BPROAD 专题 Chairs: Lawrence Appel, USA; Itamar Raz, Israel; Zhao Zhigang, China; Yu Xuefeng, China Health Effects of Sodium and Potassium Intake in China: Recent Evidence, Research Gaps, and Implications for Public Health 中国钠和钾摄入对健康的影响: 最新证据、研究差距和对公共卫生的影响 Lawrence Appel, USA 20min Blood Pressure Control Target in Type 2 Diabetes 糖尿病患者的降压治疗目标 Bi Yufang, China 20min Blood Pressure and Cardiovascular Outcome in Diabetes 糖尿病患者的血压和心血管预后 Itamar Raz, Israel 20min Antiplatelet Therapy in Patients with Coronary Artery Disease and Diabetes 冠心病合并糖尿病患者的抗血小板治疗 Li Yi,China 20min Diabetic Atherosclerosis and β-Hydroxybutyrate Dehydrogenase 1 (Bdh1)糖尿病动脉粥样硬化与β-羟基丁酸脱氢酶 Wan Qin，China 20min Research Progress of Bone Marrow Immune Cells and Weight Regain骨髓免疫与肥胖反弹研究进展 Luo Xianghang,China 20min Discussion 40Min | Session 3| Journal of Diabetes：Higher and Closer 《糖尿病杂志》：深入探索与精进 Chairs: Zachary T. Bloomgarden, USA; Domenico Accili, USA; Yang Tao, China; Liu Jianmin, China Novel Ways to Treat Beta-cell Failure 治疗细胞衰竭的新方法 Domenico Accili, USA 20min Adipose Tissue Plasticity and Metabolic Health脂肪组织可塑性与代谢健康 Bi Yan, China 20min Diabetes in the Next 10 Years 糖尿病在未来10年Zachary T. Bloomgarden, USA 20min FSH/FSHR and Glucose Homeostasis FSH/FSHR 与糖稳态 Zhu Hong, China 20min Bile Acid Signaling Linked Gut Microbiota with Antidiabetic Medications & β Cell Homeostasis 胆汁酸信号与抗糖尿病药物和β细胞稳态相关的肠道微生物群 Gu Yanyun China 20min Global Views on the Chinese Journals中国期刊走向世界 Wei Junmin, China 20min Chinese Medical Journals from the Perspective of SCISCI视角下的中国医学期刊 Liu Shihua，China 20min Discussion 40 Min |
JUNE 1 SATURDAY 2024
| CODHy Congress Scientific Program | |||
| 08:00-10:10 | Plenary Session 1: Opening Session Chairs: Wang Weiqing, China 08:00-08:20 Ceremony-Opening Speech–Ning Guang , China; Itamar Raz , Israel Opening Report Chairs: Wang Weiqing, China；Mu Yiming, China; Domenico Accili, USA 08:20-08:50 AI-Driven Precise Diagnosis and Treatment of Diabetic Nephropathy AI驱动糖尿病肾病的精准诊疗 —Member of Chinese Academy of Engineering: Chen Xiangmei, China 08:50 -09:20 Pan-risk Factors for a Comprehensive Cardiometabolic Health Management 泛危险因素的全面心血管代谢健康管理 —Member of Chinese Academy of Engineering: Ning Guang , China 09:20 -09:50 Obesity and Diabetes State of the Art 2024 ，2024年肥胖与糖尿病的最新进展 —Itamar Raz, Israel Discussion 20 min | ||
| 10:10-11:30 | Plenary Session 2: Keynote Session Chairs: Xiao Haipeng,China；Zhao Jiajun,China; Zhu Dalong,China 10:10-10:30 Advances in Cell Conversion Therapy for Type 1 Diabetes 1型糖尿病细胞转化疗法的进展 —Domenico Accili, USA 10:30-10:50 The Impact of Diabetes and Related Metabolic Diseases on Health in China: Preliminary Data from MMC中国糖尿病等代谢性疾病影响健康MMC初步数据分析 –—Wang Weiqing, China 10:50-11:10 The Role of A1C and Hyperglycemia in Diabetes Complication糖化血红蛋白和高血糖在糖尿病并发症中的作用 —Antonio Ceriello，Italy Discussion and Photo 20min | ||
| 11:30-12:00 | LUNCH BOX PICK UP and HALLS RE-SETTING | ||
| HALL A | HALL B | HALL C | |
| 12:00-14:00 | Lunch Symposium D | Lunch Symposium E | Lunch Symposium F |
| 14:00-16:00 | Session 4 | Diabetes Complications and Secondary Hypertension糖尿病并发症与继发性高血压 Chairs: Itamar Raz, Israel; Eberhard Standl, Germany; Cheng Jinluo, China; Hong Jie, China The Brain and the Prevention and Treatment of Alzheimer in Diabetic Patients 糖尿病患者的大脑以及阿尔茨海默病的预防和治疗 Itamar Raz, Israel 20min Catheter Based Adrenal Ablation for Primary Aldosteronism 经导管肾上腺消融治疗原醛症 Zhu Zhiming, China 20min Clinical Value of Cofrogliptin: In Light of Trends in the Development of Long-acting Formulations 长治久安-从长效的趋势来看考格列汀的临床价值 Wang Weiqing，China 20min Essentials for Protecting the Heart & the Vascular System by Treatment of Diabetes 糖尿病治疗中心血管系统保护要素 Eberhard Standl, Germany 20min Whole Course Management of Diabetes Retinopathy 糖尿病视网膜病变的全程管理 Wang Yufan, China 20min Discussion 20 Min | Session 5 | Microbiota and Metabolic Disease菌群与代谢性疾病 Chairs: Eran Elinav, Israel; Liu Libin, China; Tang Xulei, China Gu Wei, China Microbiome –Change in Microbiome to Cure Obesity 微生物组—宿主在健康和疾病中的相互作用 Eran Elinav, Israel 20min The biosynthesis and structural diversification of microbial natural products 菌源代谢产物的生物合成和结构多样性扩展 Ma Ming，China 20min The Gut Microbiome and Cardiometabolic Health肠道微生物与心血管代谢健康 Chen Lianmin,China 20min Phage Therapy in Metabolic Diseases噬菌体疗法在代谢性疾病中的应用 Duan Yi，China 20min Gut Microbiota and Obesity, Metabolic Regulation肠道菌群与肥胖、代谢调节 Liu Ruixin，China 20min Discussion 20 Min | Session 6 | Thyroid and Bone甲状腺与骨代谢 Chairs: Mimi I. Hu, USA; Cheng Zhifeng, China; Li Ling, China Interpretation of Practice Guideline for Diagnosis and Treatment of Hypophosphatemic Rickets/Osteomalacia 低磷性佝偻病/骨软化症诊治实践指南解读Liu Jianmin，China 20min The Current Status of Thyroid Disease in China and Some Reflections After Two Decades of Iodine Supplementation 中国20年补碘后的甲状腺疾病现况及思考 Shan Zhongyan，China 20min Interpretation of 2022 WHO Classification of Thyroid Neoplasms 2022版（第5版）甲状腺肿瘤WHO分类解读 Xie Jing，China 20min Medullary Thyroid Carcinoma: Updates on Evaluation and Management 甲状腺髓样癌：评估和治疗的最新进展 Mimi I. Hu, USA 20min From C Cell to Medullary Thyroid Carcinoma 从C细胞到甲状腺髓样癌 Ye Lei，China 20min Discussion 20 Min |
| 16:00-16:30 | Symposium G | Symposium H | Symposium I |
| 16:30-18:30 | Session 7 | Pancreatic Islets and Islet Organoids 胰岛与胰岛类器官 Chairs: Zachary T. Bloomgarden, USA; Antonio Ceriello , Italy Wang Guixia, China; Ji Qiuhe, China; Islet Organoid Transplantation: Optimizing Strategy and Future Clinical Application 胰岛类器官移植治疗的优化策略与临床前景 Zhu Dalong，China 20min Can Type 1 Diabetes be Prevented or Reversed I型糖尿病是否可以预防或逆转吗？ International: Zachary T. Bloomgarden,USA 15min China: Zhang Yifei，China 15min Islet Tansplantation：from Primary Islets to Organoids 胰岛移植:从原代胰岛到类器官 Wang Kai，China 20min Why an Early Use of SGLT-2i in Type 2 Diabetes为何早期在2型糖尿病中使用SGLT-2抑制剂 Antonio Ceriello , Italy 20min Discussion 20 Min | Session 8 | Diet and Exercise 饮食和运动 Chairs: Luc Van Gaal, Belgium; Vesna Dimitrijević Srećković, Serbia Li Yanbing, China; Qin Guijun, China; Lifestyle-new studies in nutrition and exercise 生活方式-运动和营养新研究Luc Van Gaal, Belgium 15min Amino Acid Sensing and Health 氨基酸感应与健康Guo Feifan, China 15min Microbiome and Precision Dieting 微生物组和精确节食Eran Elinav, Israel 20min Interpretation and Thoughts on Clinical Guidelines for Metabolic-Related Fatty Liver Disease 代谢相关脂肪性肝病临床解读与思考 Huang Shan，China 20min Mediterranean Diet 地中海饮食 Vesna Dimitrijević Srećković, Serbia 15min Plasma SPARC in Precision Nutrition 血清因子SPARC与精准营养 Wang Jiqiu China 15min Discussion 20 Min | Session 9 | AI and Virtual Therapy in Obesity and Diabetes 人工智能与远程诊疗在糖尿病与肥胖中的运用 Chairs: Eberhard Standl, German; Juliana Chan, HK SAR; Yan Li, China; Xiang Guangda, China AI and Virtual Therapy in Diabetes 人工智能与糖尿病 Eberhard Standl, German 20min Al and Virtual Therapy in Obesity and Diabetes – Practice in diabetes Management in Ruijin Hospital 肥胖与糖尿病的人工智能与虚拟治疗——瑞金医院糖尿病管理实践 Zhao Zhiyun，China 20min Virtual Therapy in Obesity and Diabetes – Can this Replace Face to Face Meeting 肥胖和糖尿病的远程诊疗——这可以取代面诊吗 Juliana Chan，HK SAR 20min AI Empowers MMC to Digitize and Intelligently Manage Chronic Diseases AI助力MMC数智化慢病管理 Li Zhenjie，China 20min Discussion 20 Min |